On (b)(6) 2016, a mitral valve replacement was performed.Per report, the patient's native valve appeared rheumatic.The anterior leaflet and chordae were resected and this 25 mm sjm masters series valve was implanted.The valve was noted to be functioning immediately after it was implanted on echo until the patient started to come off bypass until 2l flow one of the leaflets froze.Per report, it was initially thought that the leaflet was catching the papillary muscle and impeding performance; however while weaning from cpb, an occlusive clot in the descending aorta was noted.The patient was placed back on bypass for the removal of the valve and immediately upon opening despite full heparinization, there were strands noted.The 25 mm valve was removed, the posterior leaflet and chordae were resected, and a larger 27 mm masters series valve was implanted.It was reported the patient was on bypass for an additional hour or more to complete the entire surgical procedures.Per report, the patient had multiple existing health problems, including a thrombolytic disorder.The patient was reported to be in stable condition and transitioning to coumadin.
|
The results of this investigation concluded both leaflets were fully mobile and no damage was found to the orifice, recessed pivot areas, or leaflets.A review of the device history record showed the device met specifications prior to leaving sjm manufacturing facilities.There was no evidence found to suggest there was an intrinsic defect in the valve, as supported by the review of the device history record and the analysis performed.The cause of the reported event remains unknown; however, information from the field indicated a larger 27 mm masters series valve was implanted.
|